MediPharm Labs Completes a New Cannabis Oil Delivery to German Partner Vayamed
19 oct. 2021 07h00 HE
|
MediPharm Labs Corp.
New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis business unit of Sanity GroupVayamed is a well-established operating medical cannabis company...
Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent
31 août 2021 07h00 HE
|
MediPharm Labs Corp.
McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter...
MediPharm Labs Australia Receives Government Grant to Assist with International Expansion
19 août 2021 07h00 HE
|
MediPharm Labs Corp.
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s Manufacturing Modernisation program aimed at supporting manufacturers scaling their...
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil
18 août 2021 07h15 HE
|
MediPharm Labs Corp.
Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits issued from Health Canada. Initial deliveries will be under the...
Copperstate Farms Expands Cultivation Headquarters with New Hydrocarbon Lab
17 août 2021 12h00 HE
|
Copperstate Farms
PHOENIX, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Copperstate Farms Management, LLC, a vertically integrated cannabis company based in Arizona, today announced the completion of a new hydrocarbon lab at...
MediPharm Reports Second Quarter 2021 Results and Advances Pharmaceutical Strategy; Announces new Board Chair
16 août 2021 07h15 HE
|
MediPharm Labs Corp.
BARRIE, Ontario, Aug. 16, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in research-driven...
MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results
10 août 2021 07h00 HE
|
MediPharm Labs Corp.
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in research-driven...
MediPharm Labs Achieves Major Pharmaceutical Manufacturing Milestone: Receives Canadian GMP Pharmaceutical Drug Establishment Licence
14 juil. 2021 07h00 HE
|
MediPharm Labs Corp.
Health Canada Drug Establishment Licence allows MediPharm Labs to conduct pharmaceutical manufacturing and sale of Active Pharmaceutical Ingredients and Pharmaceutical Drug ProductsMakes MediPharm...
MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
21 juin 2021 07h00 HE
|
MediPharm Labs Corp.
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple...
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
09 avr. 2021 09h02 HE
|
WeedMD Rx Inc.
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis,...